Burning Rock Biotech earnings were -$33.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest BNR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$1.9M, down 83.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BNR reported annual earnings of -$47.5M, with -48.5% growth.
Burning Rock Biotech Earnings Reports & History FAQ
What were Burning Rock Biotech's earnings last quarter?
Burning Rock Biotech (NASDAQ: BNR) reported Q1 2025 earnings per share (EPS) of -$0.18, up 89.17% year over year. Total BNR earnings for the quarter were -$1.86 million. In the same quarter last year, Burning Rock Biotech's earnings per share (EPS) was -$1.65.
Is Burning Rock Biotech profitable or losing money?
As of the last Burning Rock Biotech earnings report, Burning Rock Biotech is currently losing money. Burning Rock Biotech's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$32.86 million, a 59.9% decrease year over year.
What was BNR's earnings growth in the past year?
As of Burning Rock Biotech's earnings date in Q3 2025, Burning Rock Biotech's earnings has grown year over year. BNR earnings in the past year totalled -$33.14 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.